Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

163.79 +2.19 (+1.36%)
Streaming Delayed Price Updated: 2:55 PM EDT, Oct 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,554,591
Open 160.00
Bid (Size) 163.74 (1)
Ask (Size) 163.77 (9)
Prev. Close 161.60
Today's Range 159.00 - 166.75
52wk Range 143.13 - 168.85
Shares Outstanding 2,628,679,824
Dividend Yield 2.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
JNJ earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
Via Benzinga

Performance

YTD
+2.39%
+2.39%
1 Month
-1.92%
-1.92%
3 Month
+9.75%
+9.75%
6 Month
+10.98%
+10.98%
1 Year
+3.97%
+3.97%

More News

Read More
Chipmaker Stocks Sink On ASML Earnings Leak, Oil Eyes Worst 1-Day Drop This Year, Small Caps Rally: What's Driving Markets Tuesday?
Via Benzinga
Johnson & Johnson’s Medtech Segment Shines With Impressive Q3 Growth
Via Talk Markets
Why NYSE:JNJ is a Top Pick for Dividend Investors.
Via Chartmill
This Is What Whales Are Betting On Johnson & Johnson
Via Benzinga
Market Whales and Their Recent Bets on JNJ Options
Via Benzinga
Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition
Via Benzinga
Johnson & Johnson Earnings Top; Dow Giant Works Toward Buy Point
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
Via Benzinga
Topics Stocks
Exposures US Equities
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q3 2024 Results
From Johnson & Johnson
Via Business Wire
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
Via Benzinga
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Via Talk Markets
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
Via Benzinga
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
Via Benzinga
Best Pharma Stocks for Long-Term Investors: Growth and Dividends
Via MarketBeat
Columbus Day: Is Stock Market Open Today?
Via Benzinga
Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
Via MarketBeat
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
Via The Motley Fool
Johnson & Johnson Dividend Stock Analysis - Saturday, Oct. 12
Via Talk Markets
Stocks Extend Weekly Win Streaks To 5
Via Talk Markets
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.